21 Feb 2020 --- Royal DSM has agreed to acquire Glycom A/S (Glycom), a major supplier of Human Milk Oligosaccharides (HMOs) for an enterprise value of €765 million (US$826 million). “The acquisition of Glycom, adds HMOs to our portfolio, a novel high-growth ingredient for next generation Early Life Nutrition solutions. It also enables us to accelerate growth and provide customers with innovative solutions for our Human Nutrition Business,” a DSM spokesperson tells NutritionInsight. The transaction is expected to close in the second quarter of 2020.
